Loading...
Loading...
India's insulin imports from ISRAEL total $268 across 1 shipments from 1 foreign suppliers. PROSPEC TANY TECHNOGENE LIMITED leads with $268 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include IMPERIAL LIFE SCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for insulin โ a concentrated sourcing relationship with select suppliers from ISRAEL.

PROSPEC TANY TECHNOGENE LIMITED is the leading Insulin supplier from ISRAEL to India, with import value of $268 across 1 shipments. The top 5 suppliers โ PROSPEC TANY TECHNOGENE LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PROSPEC TANY TECHNOGENE LIMITED | $268 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IMPERIAL LIFE SCIENCES PRIVATE LIMITED | $268 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Insulin suppliers from ISRAEL to India include PROSPEC TANY TECHNOGENE LIMITED. The leading supplier is PROSPEC TANY TECHNOGENE LIMITED with import value of $268 USD across 1 shipments. India imported Insulin worth $268 USD from ISRAEL in total across 1 shipments.
India imported Insulin worth $268 USD from ISRAEL across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Insulin sourced from ISRAEL include IMPERIAL LIFE SCIENCES PRIVATE LIMITED. The largest buyer is IMPERIAL LIFE SCIENCES PRIVATE LIMITED with $268 in imports across 1 shipments.
The total value of Insulin imports from ISRAEL to India is $268 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists